XML 44 R73.htm IDEA: XBRL DOCUMENT v2.4.1.9
Investments - Additional Information (Detail)
12 Months Ended 12 Months Ended
Dec. 31, 2014
USD ($)
Dec. 31, 2013
USD ($)
Dec. 31, 2012
USD ($)
Dec. 31, 2014
Significant Unconsolidated Joint Venture
USD ($)
Dec. 31, 2013
Significant Unconsolidated Joint Venture
USD ($)
Dec. 31, 2012
Significant Unconsolidated Joint Venture
USD ($)
Dec. 31, 2014
Joint Venture Saudi Organometallic Chemicals Company
SAR
Dec. 31, 2012
Joint Venture Saudi Organometallic Chemicals Company
USD ($)
Dec. 31, 2014
Joint Venture Saudi Organometallic Chemicals Company
USD ($)
Dec. 31, 2013
Joint Venture Saudi Organometallic Chemicals Company
Dec. 31, 2012
Eurecat S.A.
EUR (€)
Dec. 31, 2014
Eurecat S.A.
USD ($)
Dec. 31, 2013
Eurecat S.A.
USD ($)
Dec. 31, 2014
Nippon Aluminum Alkyls
Dec. 31, 2013
Nippon Aluminum Alkyls
Dec. 31, 2012
Nippon Aluminum Alkyls
Dec. 31, 2014
Magnifin Magnesiaprodukte GmbH & Co. KG
Dec. 31, 2013
Magnifin Magnesiaprodukte GmbH & Co. KG
Dec. 31, 2012
Magnifin Magnesiaprodukte GmbH & Co. KG
Dec. 31, 2014
Nippon Ketjen Company Limited
Dec. 31, 2013
Nippon Ketjen Company Limited
Dec. 31, 2012
Nippon Ketjen Company Limited
Dec. 31, 2014
Eurecat S.A.
Dec. 31, 2013
Eurecat S.A.
Dec. 31, 2012
Eurecat S.A.
Dec. 31, 2014
Fabrica Carioca de Catalisadores S.A.
Dec. 31, 2013
Fabrica Carioca de Catalisadores S.A.
Dec. 31, 2012
Fabrica Carioca de Catalisadores S.A.
Dec. 31, 2014
Stannica, LLC
Dec. 31, 2013
Stannica, LLC
Dec. 31, 2012
Stannica, LLC
Dec. 31, 2014
Stannica Llc
USD ($)
Dec. 31, 2013
Stannica Llc
USD ($)
Dec. 31, 2014
Benefit Protection Trust
USD ($)
Dec. 31, 2013
Benefit Protection Trust
USD ($)
Schedule of Investments [Line Items]                                                                      
Investment in significant unconsolidated joint ventures       $ 154,400,000alb_InvestmentInSignificantUnconsolidatedJointVentures
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
$ 172,900,000alb_InvestmentInSignificantUnconsolidatedJointVentures
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
                                                           
Equity in net income of unconsolidated investments (net of tax) 35,742,000us-gaap_IncomeLossFromEquityMethodInvestments 31,729,000us-gaap_IncomeLossFromEquityMethodInvestments 38,067,000us-gaap_IncomeLossFromEquityMethodInvestments 35,400,000us-gaap_IncomeLossFromEquityMethodInvestments
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
31,500,000us-gaap_IncomeLossFromEquityMethodInvestments
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
37,000,000us-gaap_IncomeLossFromEquityMethodInvestments
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
                                                         
Undistributed earnings from equity method investees       112,900,000us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
117,100,000us-gaap_RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
                                                           
Dividends received from unconsolidated investments 40,688,000us-gaap_EquityMethodInvestmentDividendsOrDistributions 21,632,000us-gaap_EquityMethodInvestmentDividendsOrDistributions 26,908,000us-gaap_EquityMethodInvestmentDividendsOrDistributions 39,600,000us-gaap_EquityMethodInvestmentDividendsOrDistributions
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
20,500,000us-gaap_EquityMethodInvestmentDividendsOrDistributions
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
25,600,000us-gaap_EquityMethodInvestmentDividendsOrDistributions
/ alb_JointVentureAxis
= alb_SignificantUnconsolidatedJointVentureMember
                                                         
Investments in unconsolidated joint ventures exceeded the amount of underlying equity in net assets 7,000,000us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity 8,400,000us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity                                                                  
Excess amount paid for joint ventures remaining to be amortized 1,000,000alb_ExcessAmountPaidForJointVenturesRemainingToBeAmortized 1,400,000alb_ExcessAmountPaidForJointVenturesRemainingToBeAmortized                                                                  
Carrying value of unconsolidated investment 0us-gaap_EquityMethodInvestments 0us-gaap_EquityMethodInvestments                                                           6,200,000us-gaap_EquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= alb_StannicaLLCMember
5,500,000us-gaap_EquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= alb_StannicaLLCMember
   
Marketable equity securities 23,974,000us-gaap_MarketableSecuritiesNoncurrent 23,801,000us-gaap_MarketableSecuritiesNoncurrent                                                               22,200,000us-gaap_MarketableSecuritiesNoncurrent
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_TrustForBenefitOfEmployeesMember
23,000,000us-gaap_MarketableSecuritiesNoncurrent
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_TrustForBenefitOfEmployeesMember
Long-term advances to joint ventures 7,499,000us-gaap_PaymentsForAdvanceToAffiliate 0us-gaap_PaymentsForAdvanceToAffiliate 24,959,000us-gaap_PaymentsForAdvanceToAffiliate       28,100,000us-gaap_PaymentsForAdvanceToAffiliate
/ alb_JointVentureAxis
= alb_JointVentureSaudiOrganometallicChemicalsCompanyMember
22,500,000us-gaap_PaymentsForAdvanceToAffiliate
/ alb_JointVentureAxis
= alb_JointVentureSaudiOrganometallicChemicalsCompanyMember
    1,900,000us-gaap_PaymentsForAdvanceToAffiliate
/ alb_JointVentureAxis
= alb_JointVentureEurecatSAMember
                                               
Long-term advances to joint ventures $ 34,084,000us-gaap_AdvancesToAffiliate [1] $ 25,124,000us-gaap_AdvancesToAffiliate [1]             $ 7,500,000us-gaap_AdvancesToAffiliate
/ alb_JointVentureAxis
= alb_JointVentureSaudiOrganometallicChemicalsCompanyMember
    $ 2,300,000us-gaap_AdvancesToAffiliate
/ alb_JointVentureAxis
= alb_JointVentureEurecatSAMember
$ 2,600,000us-gaap_AdvancesToAffiliate
/ alb_JointVentureAxis
= alb_JointVentureEurecatSAMember
                                           
Ownership percentage                 50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ alb_JointVentureAxis
= alb_JointVentureSaudiOrganometallicChemicalsCompanyMember
    50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ alb_JointVentureAxis
= alb_JointVentureEurecatSAMember
  50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureNipponAluminumAlkylsMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureNipponAluminumAlkylsMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureNipponAluminumAlkylsMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureMagnifinMagnesiaprodukteGmbhAndCompanyKgMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureMagnifinMagnesiaprodukteGmbhAndCompanyKgMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureMagnifinMagnesiaprodukteGmbhAndCompanyKgMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureNipponKetjenCompanyLimitedMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureNipponKetjenCompanyLimitedMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureNipponKetjenCompanyLimitedMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureEurecatSAMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureEurecatSAMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureEurecatSAMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureFabricaCariocaDeCatalisadoresMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureFabricaCariocaDeCatalisadoresMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureFabricaCariocaDeCatalisadoresMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureStannicaLLCMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureStannicaLLCMember
50.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ dei_LegalEntityAxis
= alb_JointVentureStannicaLLCMember
       
Interest rate margin over LIBOR                 1.275%us-gaap_LoansReceivableBasisSpreadOnVariableRate
/ alb_JointVentureAxis
= alb_JointVentureSaudiOrganometallicChemicalsCompanyMember
                                                   
Interest rate percentage                 1.53%alb_LoansAndLeasesReceivableInterestRate
/ alb_JointVentureAxis
= alb_JointVentureSaudiOrganometallicChemicalsCompanyMember
1.52%alb_LoansAndLeasesReceivableInterestRate
/ alb_JointVentureAxis
= alb_JointVentureSaudiOrganometallicChemicalsCompanyMember
                                                 
Long-term advances to joint venture, maturity date             Dec. 31, 2021                                                        
[1] See Note 9, “Investments.”